Compton Wealth Advisory Group LLC Acquires 645 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Compton Wealth Advisory Group LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 8.3% in the 4th quarter, HoldingsChannel reports. The fund owned 8,374 shares of the healthcare conglomerate’s stock after purchasing an additional 645 shares during the period. UnitedHealth Group makes up approximately 1.4% of Compton Wealth Advisory Group LLC’s investment portfolio, making the stock its 18th biggest holding. Compton Wealth Advisory Group LLC’s holdings in UnitedHealth Group were worth $4,409,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. State Street Corp boosted its holdings in UnitedHealth Group by 1.7% during the second quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate’s stock worth $22,260,241,000 after purchasing an additional 764,872 shares during the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Morgan Stanley boosted its stake in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC boosted its stake in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its stake in UnitedHealth Group by 3.5% in the second quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after acquiring an additional 399,739 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Piper Sandler lowered their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Truist Financial reissued a “buy” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Thursday, November 30th. Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $579.33.

Check Out Our Latest Report on UNH

UnitedHealth Group Trading Up 0.3 %

Shares of UNH stock traded up $1.60 on Friday, hitting $494.70. 3,820,008 shares of the company’s stock traded hands, compared to its average volume of 4,274,309. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company’s fifty day simple moving average is $502.66 and its 200 day simple moving average is $518.44. The stock has a market capitalization of $456.08 billion, a price-to-earnings ratio of 20.75, a P/E/G ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter last year, the firm earned $5.34 EPS. The firm’s quarterly revenue was up 14.1% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.